350 results
8-K
EX-99.1
MEIP
MEI Pharma Inc
21 May 24
Regulation FD Disclosure
1:00pm
Forward Looking Statements Certain information contained in this communication that are not historical in nature are "forward-looking statements" within … Murine Models3 1. Lesnick et al. J Clin Oncol.2020;38(15_suppl):e20009; 2. Paiva et al, PLoS ONE. 2015;10(11):e0143685; 3. Dey et al. Nature Sci Rep
8-K
EX-99.1
MEIP
MEI Pharma Inc
9 May 24
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
4:02pm
that are not historical in nature are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E
8-K
EX-1.1
MEIP
MEI Pharma Inc
21 Feb 24
Other Events
4:00pm
not be required to specify the nature of such proposed transaction), (A) offer, pledge, announce the intention to sell, sell, contract to sell, sell any … . The Company agrees that it will not claim that the Agent has rendered advisory services of any nature or
respect, or owes a fiduciary or similar duty
8-K
EX-99.1
gsr613bg45irj 6e
13 Feb 24
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
5:05pm
8-K
EX-99.1
me1zuy06
11 Dec 23
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
4:00pm
8-K
EX-99.1
l84j1cw9m8g3lshoh
9 Nov 23
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
4:06pm
DFAN14A
sc5dmtw 71j
1 Nov 23
Additional proxy materials by non-management
5:15pm
DEFA14A
g1bmvaxj0po7mdt
1 Nov 23
Additional proxy soliciting materials
4:54pm
8-K
EX-99.1
tlxefw j27jojyh
1 Nov 23
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
4:01pm
8-K
EX-10.1
jtcl8l85dl o2pc4110w
1 Nov 23
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
4:01pm
DEFA14A
vuca6
18 Oct 23
Additional proxy soliciting materials
12:00am
DEFC14A
fdiib
17 Oct 23
Proxy in contested solicitation
5:28pm